BRCA1 shields vascular smooth muscle cells from oxidative stress

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 6, 2014, Pages 1946-1955.e1

  Lovren, Fina ^a,b   Pan, Yi ^a,b   Quan, Adrian ^a,b   Singh, Krishna K ^a,b   Khan, Rishad ^a,b   Gupta, Nandini ^d   Brezden Masley, Christine ^a,b,c   Teoh, Hwee ^a,b   Wheatcroft, Mark D ^a,b,c   Al Omran, Mohammed ^a,b,c   Verma, Subodh ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEART RATE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER; TELEMETRY; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BLOOD PRESSURE; BRCA1 PROTEIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC THERAPY; HISTONES; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDANTS; OXIDATIVE STRESS; PHOSPHOPROTEINS; RAD51 RECOMBINASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; TRANSFECTION;

EID: 84901199535     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.09.060     Document Type: Article

References (29)

1. A.C. Montezano, and R.M. Touyz Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research Antioxid Redox Signal June 6, 2013 [Epub ahead of print]
2. Y. Zhou, H. Yan, M. Guo, J. Zhu, Q. Xiao, and L. Zhang Reactive oxygen species in vascular formation and development Oxid Med Cell Longev 2013 2013 374963
3. N.L. Sehgel, Y. Zhu, Z. Sun, J.P. Trzeciakowski, Z. Hong, and W.C. Hunter et al. Increased vascular smooth muscle cell stiffness; a novel mechanism for aortic stiffness in hypertension Am J Physiol Heart Circ Physiol 305 2013 H1281 H1287
4. P. Lacolley, V. Regnault, A. Nicoletti, Z. Li, and J.B. Michel The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles Cardiovasc Res 95 2012 194 204
5. F. Lovren, Y. Pan, A. Quan, K.K. Singh, P.C. Shukla, and N. Gupta et al. MicroRNA-145 targeted therapy reduces atherosclerosis Circulation 126 2012 S81 S90
6. L. Denes, L. Entz, and V. Jancsik Restenosis and therapy Int J Vasc Med 2012 2012 406236
7. A. Della Corte, C. Quarto, C. Bancone, C. Castaldo, F. Di Meglio, and D. Nurzynska et al. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling J Thorac Cardiovasc Surg 135 2008 8 18 e1-2
8. R.A. Greenberg Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network Chromosoma 117 2008 305 317
9. B. Sobhian, G. Shao, D.R. Lilli, A.C. Culhane, L.A. Moreau, and B. Xia et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites Science 316 2007 1198 1202
10. P.C. Shukla, K.K. Singh, A. Quan, M. Al-Omran, H. Teoh, and F. Lovren et al. BRCA1 is an essential regulator of heart function and survival following myocardial infarction Nat Commun 2 2011 593
11. K.K. Singh, P.C. Shukla, A. Quan, M. Al-Omran, F. Lovren, and Y. Pan et al. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis J Thorac Cardiovasc Surg 146 2013 949 960.e4
12. K.K. Singh, P.C. Shukla, A. Quan, J.F. Desjardins, F. Lovren, and Y. Pan et al. BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure J Biol Chem 287 2012 6604 6614
13. K.K. Singh, P.C. Shukla, B. Yanagawa, A. Quan, F. Lovren, and Y. Pan et al. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1 J Thorac Cardiovasc Surg 146 2013 702 709
14. H. Teoh, A. Quan, A.K. Creighton, K.W. Annie Bang, K.K. Singh, and P.C. Shukla et al. BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis Gene Ther 20 2013 51 61
15. A. Manea, L.I. Tanase, M. Raicu, and M. Simionescu Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells Biochem Biophys Res Commun 396 2010 901 907
16. L.A. Pescatore, D. Bonatto, F.L. Forti, A. Sadok, H. Kovacic, and F.R. Laurindo Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation J Biol Chem 287 2012 29290 29300
17. A.E. Dikalova, M.C. Gongora, D.G. Harrison, J.D. Lambeth, S. Dikalov, and K.K. Griendling Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling Am J Physiol Heart Circ Physiol 299 2010 H673 H679
18. A.L. Sheehan, S. Carrell, B. Johnson, B. Stanic, B. Banfi, and F.J. Miller Jr. Role for Nox1 NADPH oxidase in atherosclerosis Atherosclerosis 216 2011 321 326
19. A.J. Valente, T. Yoshida, S.N. Murthy, S.S. Sakamuri, M. Katsuyama, and R.A. Clark et al. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18 Am J Physiol Heart Circ Physiol 303 2012 H282 H296
20. K. Matsuno, H. Yamada, K. Iwata, D. Jin, M. Katsuyama, and M. Matsuki et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice Circulation 112 2005 2677 2685
21. X. Xu, K.U. Wagner, D. Larson, Z. Weaver, C. Li, and T. Ried et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation Nat Genet 22 1999 37 43
22. G. Casey The BRCA1 and BRCA2 breast cancer genes Curr Opin Oncol 9 1997 88 93
23. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, and S. Tavtigian et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
24. R. Scully, and D.M. Livingston In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature 408 2000 429 432
25. R. Hakem, J.L. de la Pompa, and T.W. Mak Developmental studies of Brca1 and Brca2 knock-out mice J Mammary Gland Biol Neoplasia 3 1998 431 445
26. K. Zbuk, C. Xie, R. Young, M. Heydarpour, G. Pare, and A.D. Davis et al. BRCA2 variants and cardiovascular disease in a multi-ethnic study BMC Med Genet 13 2012 56
27. P.L. Mai, N. Chatterjee, P. Hartge, M. Tucker, L. Brody, and J.P. Struewing et al. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma PLoS One 4 2009 e4812
28. L. Bordeleau, L. Lipscombe, J. Lubinski, P. Ghadirian, W.D. Foulkes, and S. Neuhausen et al. Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations Cancer 117 2011 1812 1818
29. K. Ozaki, H. Sato, K. Inoue, T. Tsunoda, Y. Sakata, and H. Mizuno et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations Nat Genet 41 2009 329 333